07/s13555-022-00782-2.

Nemluvio®U.S. Prescribing Information. Availableonline. Accessed February 2026.

Nemluvio®European Medicines Agency. Summary of Product Characteristics. Availableonline. Accessed February 2026.

ClinicalTrials.Gov. A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) (NCT04501679). Availableonline. Accessed February 2026.

ClinicalTrials.Gov. Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) (NCT04501666). Availableonline. Accessed February 2026.

Chugai Pharmaceutical Co., Ltd. Maruho Obtained Regulatory Approval for Mitchga, the first Antibody Targeting IL-31 for Itching Associated with Atopic Dermatitis. Availableonline. Accessed February 2026.

Chugai Pharmaceutical Co., Ltd. Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcu
=*=*=*=*=*=
当前为第9/12页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页